453 related articles for article (PubMed ID: 8230286)
1. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
[TBL] [Abstract][Full Text] [Related]
2. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
[TBL] [Abstract][Full Text] [Related]
3. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
Lacey LM; Hynes DM; Kaluzny AD
J Health Hum Resour Adm; 1992; 14(3):307-26. PubMed ID: 10118501
[TBL] [Abstract][Full Text] [Related]
4. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
[TBL] [Abstract][Full Text] [Related]
5. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
Kaluzny AD; Lacey LM; Warnecke R; Hynes DM; Morrissey J; Ford L; Sondik E
Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
[TBL] [Abstract][Full Text] [Related]
6. Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.
Kaluzny AD; Ricketts T; Warnecke R; Ford L; Morrissey J; Gillings D; Sondik EJ; Ozer H; Goldman J
J Natl Cancer Inst; 1989 Nov; 81(22):1717-25. PubMed ID: 2681795
[TBL] [Abstract][Full Text] [Related]
7. Accrual to the Breast Cancer Prevention Trial by participating Community Clinical Oncology Programs: a panel data analysis.
Klabunde CN; Kaluzny AD
Breast Cancer Res Treat; 1995 Jul; 35(1):43-50. PubMed ID: 7612903
[TBL] [Abstract][Full Text] [Related]
8. Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.
Kaluzny AD; Lacey LM; Warnecke R; Morrissey JP; Sondik E; Ford L
Cancer Epidemiol Biomarkers Prev; 1994; 3(3):261-9. PubMed ID: 8019377
[TBL] [Abstract][Full Text] [Related]
9. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.
Holmes DR; Major J; Lyonga DE; Alleyne RS; Clayton SM
Am J Surg; 2012 Apr; 203(4):415-22. PubMed ID: 21996347
[TBL] [Abstract][Full Text] [Related]
10. Provider-based research networks demonstrate greater hospice use for minority patients with lung cancer.
Penn DC; Stitzenberg KB; Cobran EK; Godley PA
J Oncol Pract; 2014 Jul; 10(4):e182-90. PubMed ID: 24781367
[TBL] [Abstract][Full Text] [Related]
11. Cancer control research for community programs: the National Cancer Institute initiative.
Hunter CP; Bavier AR; Ford LG
Cancer Detect Prev; 1990; 14(6):633-7. PubMed ID: 2257561
[TBL] [Abstract][Full Text] [Related]
12. Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.
Dimond EP; St Germain D; Nacpil LM; Zaren HA; Swanson SM; Minnick C; Carrigan A; Denicoff AM; Igo KE; Acoba JD; Gonzalez MM; McCaskill-Stevens W
Clin Trials; 2015 Jun; 12(3):246-56. PubMed ID: 25691600
[TBL] [Abstract][Full Text] [Related]
13. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
[TBL] [Abstract][Full Text] [Related]
14. Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.
Carpenter WR; Fortune-Greeley AK; Zullig LL; Lee SY; Weiner BJ
Contemp Clin Trials; 2012 Jan; 33(1):46-54. PubMed ID: 21986391
[TBL] [Abstract][Full Text] [Related]
15. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.
Chen MS; Lara PN; Dang JH; Paterniti DA; Kelly K
Cancer; 2014 Apr; 120 Suppl 7(0 7):1091-6. PubMed ID: 24643646
[TBL] [Abstract][Full Text] [Related]
16. The NCI Community Oncology Research Program: what every clinician needs to know.
McCaskill-Stevens W; Lyss AP; Good M; Marsland T; Lilenbaum R
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714464
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials in the community. The community clinical oncology program experience.
Cobau CD
Cancer; 1994 Nov; 74(9 Suppl):2694-700. PubMed ID: 7954289
[TBL] [Abstract][Full Text] [Related]
18. The effects of managed care and competition on community-based clinical research.
Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
[TBL] [Abstract][Full Text] [Related]
19. Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Patient Accrual in Puerto Rico.
Kunos CA; Massett HA; Galassi A; Walker JL; Good MJ; Díaz LB; McCaskill-Stevens W
Front Oncol; 2018; 8():102. PubMed ID: 29692980
[TBL] [Abstract][Full Text] [Related]
20. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]